ArticleOxford medical case reports2026

VEXAS syndrome presenting with severe cutaneous manifestations, inflammatory arthritis, and myelodysplastic syndrome treated with Ruxolitinib.

Jared Tesch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.